1-(2,4-二氯苄基)-1H-吲唑-3-碳酰肼

1-(2,4-二氯苄基)-1H-吲唑-3-碳酰肼

中文名称1-(2,4-二氯苄基)-1H-吲唑-3-碳酰肼
中文同义词1-(2,4-二氯苄基)-1H-吲唑-3-碳酰肼;男用口服避孕药;ADJUDIN,通道阻断剂
英文名称Adjudin
英文同义词1-(2,4-dichlorobenzyl)indazole-3-carbohydrazide;AF-2364;1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide;Adjudin, AF-2364;Adjudin;1-[(2,4-Dichlorophenyl)methyl]-1H-indazole-3-carboxylic acid hydrazide;CS-2018;1-(2,4-Dichloro-benzyl)-1H-indazole-3-carboxylic acid hydrazide
CAS号252025-52-8
分子式C15H12Cl2N4O
分子量335.19
EINECS号
相关类别小分子抑制剂;小分子抑制剂,天然产物;定制中心;Inhibitors;pharmaceutical intermedaite
Mol文件252025-52-8.mol
结构式1-(2,4-二氯苄基)-1H-吲唑-3-碳酰肼 结构式

1-(2,4-二氯苄基)-1H-吲唑-3-碳酰肼 性质

密度1.51±0.1 g/cm3(Predicted)
储存条件Store at -20°C
溶解度DMSO:34.56(最大浓度 mg/mL);103.11(最大浓度 mM)
DMF:30.0(最大浓度 mg/mL);89.5(最大浓度 mM)
DMF:PBS ( pH 7.2) (1:20):0.05(最大浓度 mg/mL);0.15(最大浓度 mM)
形态结晶固体
酸度系数(pKa)11.88±0.30(Predicted)

1-(2,4-二氯苄基)-1H-吲唑-3-碳酰肼 用途与合成方法

Adjudin【男用口服避孕药(1-(2,4-二氯苄基)-1H-吲唑-3-碳酰肼)】系Lonidamine衍生物。以往在大鼠、家兔及猎犬研究证明Adjudin【男用口服避孕药(1-(2,4-二氯苄基)-1H-吲唑-3-碳酰肼)】是以种潜在的男性口服避孕药,它通过干扰睾丸支持细胞和生精细胞的粘附连接,由此引起成熟前生精上皮精子细胞释放,导致雄性不育。然而,Adjudin【男用口服避孕药(1-(2,4-二氯苄基)-1H-吲唑-3-碳酰肼)】是否干扰人精子的受精能力及其可能的作用机制,至今尚未研究。Adjudin (AF-2364) 是一种有效的男性避孕药,也是一种有效的 Cl⁻ channels 的阻滞剂。Adjudin 通过抑制 NF-κB p65核易位和DNA结合活性以及 ERK MAPK磷酸化而具有抗炎特性。
TargetValue
Cl⁻ channel
()
NF-κB
()
ERK
()

Adjudin is a potent blocker of Cl - channels: disrupting Cl - ion transport function results in a decline in sperm capacitation and fertilizing ability in humans in vitro. Adjudin (ADD) is a mitochondria inhibitor. Adjudin is a molecule that mediates adherens junction disruption at the Sertoli-germ cell interface. To investigate the effect of Adjudin on cancer cells, more than ten different types of human or mice cancer cell lines are treated with increasing concentrations of Adjudin and the cell proliferation is measured by the modified MTT assay. Adjudin inhibits cell proliferation in a dose dependent manner in SGC-7901 (human gastric adenocarcinoma cell), MDA-MB-231 (human breast adenocarcinoma cell), Smmc-7721 (human hepatoma cell) and MIA Paca-2 (human pancreatic adenocarcinoma cell) cells. The IC 50 of Adjudin is determined to be 58.0 µM, 13.8 µM, 72.3 µM and 52.7 µM against SGC-7901, MDA-MB-231, Smmc-7721 and MIA Paca-2 cells, respectively, after treatment for 24 h. Similar results are obtained in other human and mice cancer cell lines. The IC 50 of Adjudin in A549 cells and PC3 cells is 63.1 µM and 93.0 µM, respectively. For WI-38 and BPH-1 cells, the IC 50 of Adjudin can be observed at more than 300 µM and 200 µM, respectively, which is about 5 times and 2 times more than that for the cancer cell lines A549 and PC3.

To determine whether Adjudin can inhibit lung and prostate cancer growth in vivo, the effect of Adjudin is tested in a subcutaneous model of lung and prostate cancer. Human lung carcinoma cells A549 and prostate carcinoma cells PC3 are injected into athymic nude mice subdermally at the lower back site respectively. Mice are then randomized into two treatment groups with similar mean tumor sizes: Adjudin and vehicle (control). Approximately 2 weeks after tumor inoculation Adjudin is injected intraperitoneally once every three days in lung carcinoma cells and every other day in prostate carcinoma cells at 100 mg/kg. Adjudin treatment can be well tolerated in rodent. And Adjudin-treated mice show significant tumor growth inhibition compared with the control group (P<0.0001 in the human lung carcinoma cells A549 and P=0.006 in the prostate carcinoma cells PC3).

安全信息

MSDS信息

更新日期产品编号产品名称CAS号包装价格
2024/01/25HY-18996男用口服避孕药
Adjudin
252025-52-85mg700元
2024/01/25HY-18996男用口服避孕药
Adjudin
252025-52-810mM * 1mLin DMSO770元

1-(2,4-二氯苄基)-1H-吲唑-3-碳酰肼 上下游产品信息

"1-(2,4-二氯苄基)-1H-吲唑-3-碳酰肼"相关产品信息
促甲状腺素 粉蝶霉素A 庚酸睾酮
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 | 评选活动 | HS海关编码 | MSDS查询 | 化工站点

Copyright © 2016-2023 ChemicalBook 版权所有  京ICP备07040585号  京公海网安备11010802032676号  

互联网增值电信业务经营许可证:京ICP证150597号  互联网药品信息服务资格证编号(京)-非经营性-2015-0073  信息系统安全等级保护备案证明(三级)  营业执照公示

根据相关法律法规和本站规定,单位或个人购买相关危险物品应取得有效的资质、资格条件。
参考《应急管理部等多部门关于加强互联网销售危险化学品安全管理的通知 (应急〔2022〕119号)》《互联网危险物品信息发布管理规定》